PDK1 and nonpapillary renal cell carcinoma: Taken all together, we concluded that FTO overexpression decreases the m6A modification level of PDK1, which prevents degradation of PDK1 mRNA induced by YTHDF2, and then enforced PDK1 promotes progression of ccRCC via AKT phosphorylation (Fig. 7).